A detailed history of Versant Capital Management, Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 316 shares of AGIO stock, worth $12,346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
316
Holding current value
$12,346
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 07, 2025

BUY
$24.53 - $35.75 $7,751 - $11,297
316 New
316 $10,000
Q2 2023

Jul 10, 2023

BUY
$21.38 - $29.19 $1,368 - $1,868
64 New
64 $1,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.14B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.